(Reuters) – A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer’s disease, although conclusive proof from a more formal trial could be about five years away.
(Reuters) – A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer’s disease, although conclusive proof from a more formal trial could be about five years away.
